AKERO THERAPEUTICS, INC. - Common Stock (AKRO)

CUSIP: 00973Y108

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / Common Stock
Shares outstanding
82,872,659
Total 13F shares
34,862,359
Share change
-433,785
Total reported value
$329,587,739
Put/Call ratio
0%
Price per share
$9.45
Number of holders
107
Value change
-$12,722,696
Number of buys
57
Number of sells
37

Quarterly Holders Quick Answers

What is CUSIP 00973Y108?
CUSIP 00973Y108 identifies AKRO - AKERO THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of AKRO - AKERO THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of AKERO THERAPEUTICS, INC. - Common Stock (AKRO) as of Q2 2022

As of 30 Jun 2022, AKERO THERAPEUTICS, INC. - Common Stock (AKRO) was held by 107 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 34,862,359 shares. The largest 10 holders included Skorpios Trust, JANUS HENDERSON GROUP PLC, ALKEON CAPITAL MANAGEMENT LLC, Point72 Asset Management, L.P., Atlas Venture Life Science Advisors, LLC, venBio Partners LLC, BlackRock Inc., Yiheng Capital Management, L.P., Redmile Group, LLC, and HHLR ADVISORS, LTD.. This page lists 107 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders
98
Q2 2022 holders
107
Holder diff
9
Investor Q1 2022 Shares Q2 2022 Shares Share Diff Share Chg % Q1 2022 Value $ Q2 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .